SIME DIAGNOSTICS
Updated 625 days ago
Private Limited Company
- Active - 08881197 (CH)
- Age: 11 years
- ID: 47934723/33
43 MANCHESTER STREET LONDON ENGLAND W1U 7LP
• 72110 - Research and experimental development on biotechnology
SIME Diagnostics is a global Medtech company headquartered in London. SIME was founded in 2014 based on an invention by an award winning mathematician and a world renowned neonatologist, with the goal of revolutionising medicine by predicting respiratory disease in minutes at the point-of-care... SIME are shaping a future without acute respiratory disease. The company's patented platform consists of a compact cloud connected device and reagent-free disposable designed for point-of-care use in intensive care units. Enabling the prediction of acute respiratory diseases within 15 minutes from routinely collected samples. The first product to market is a rapid test for neonatal lung maturity (respiratory distress syndrome). Alongside powering predictive diagnostics, the company's Clinical AI Platform also generates millions of unique datapoints - which are analysed by proprietary AI to drive rapid product development and deliver novel disease insights... This revolutionary tool enables..
Also known as: SIME DIAGNOSTICS LIMITED, SIME DIAGNOSTICS LTD
Registration numbers: 08881197 (CH)